Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details Narrative)

Stockholders' Deficit (Details Narrative) - USD ($)					1 Months Ended		3 Months Ended					9 Months Ended		12 Months Ended
Stockholders' Deficit (Details Narrative) - USD ($)	May 12, 2019	Jul. 23, 2018	Jul. 16, 2018	Aug. 14, 2017	Mar. 27, 2019	Sep. 30, 2017	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Sep. 18, 2018	Sep. 17, 2018	Jul. 20, 2018
Common stock shares authorized							10,000,000,000					10,000,000,000		10,000,000,000	10,000,000,000
Common stock par value							$ 0.0001					$ 0.0001		$ 0.0001	$ 0.0001	$ 0.01
Preferred stock shares authorized							5,000,000					5,000,000			5,000,000
Preferred stock par value							$ 0.01					$ 0.01			$ 0.01
Number of common stock issued, value									$ 661,381	$ 3,957,767
Stock conversion share price									$ 991,578	$ 4,037,089	$ 3,056,674
Common stock shares issued							8,398,936,775					8,398,936,775		128,567,273
Common stock shares outstanding							8,398,936,775					8,398,936,775		128,567,273
Recognized stock stock-based compensation							$ 8,650					$ 25,950	$ 739,729
Interest expense							5,400,000					9,500,000
Amortization of debt discount												6,386,305	$ 16,080,270
Employees and Directors [Member] \| Restricted Stock [Member]
Number of restricted stock issued													142,667
Recognized stock stock-based compensation													$ 477,933
Stock issued price per share									$ 3.35				$ 3.35
2007 Equity Plan [Member]
Stock option expense												$ 25,950	$ 72,590
Weighted average period												6 years 6 months
Intrinsic value of options exercisable							$ 0					$ 0
2007 Equity Plan [Member] \| Restricted Stock [Member]
Number of restricted stock issued were forfeited												123
2007 Equity Plan [Member] \| Employees and Directors [Member] \| Restricted Stock [Member]
Number of restricted stock issued				364
Common Stock [Member]
Number of common stock issued								119,615,384	768,548	572,480	151,200	119,615,384
Number of common stock issued, value								$ 11,961	$ 77	$ 57	$ 15
Stock conversion share price									$ 165	$ 157	$ 67
Conversion of stock into shares									1,649,059	1,571,000	666,621
Cashless exercise warrants							755,000,000					755,000,000
Number of shares converted												8,150,754,118		106,335,991
Number of restricted stock issued											142,667
Warrants [Member]
Number of warrants issued as anti-dilution provision												582,200,000,000
Warrant expiration date	Mar. 31, 2022
Change in fair value of warrants	$ 5,400,000				$ 4,100,000
Discount on debentures									$ 8,300,000				300,000
Series G Preferred Stock [Member]
Preferred stock shares authorized							14,000					14,000		14,000
Preferred stock par value							$ 0.01					$ 0.01		$ 0.01
Preferred stock shares outstanding							215					215		215
Preferred stock, stated value							$ 1,000					$ 1,000
Weighted average common stock price percentage												85.00%
Series H Preferred Stock [Member]
Preferred stock shares authorized							14,202					14,202		14,202
Preferred stock par value							$ 0.01					$ 0.01		$ 0.01
Preferred stock shares outstanding							10					10		60
Preferred stock, stated value							$ 1,000					$ 1,000
Weighted average common stock price percentage												85.00%
Series F Convertible Preferred Stock [Member]
Preferred stock shares outstanding							1,750,000					1,750,000
Series F Convertible Preferred Stock [Member] \| Genomas, Inc [Member]
Number of common stock issued						1,750,000
Number of common stock issued, value						$ 174,097
Stock conversion share price						$ 14,625
Conversion of stock into shares						120
Preferred stock price per share for unpaid dividend						$ 1.95
Series J Convertible Preferred Stock [Member]
Common stock shares authorized																	250,000
Preferred stock shares outstanding							250,000					250,000
Series J Convertible Preferred Stock [Member] \| Exchange Agreement [Member] \| Alcimede LLC [Member]
Number of shares issued upon conversion, value		$ 250,000
Number of shares issued upon conversion		250,000
Conversion price, per share		$ 1.00
Cumulative dividends percentage		8.00%
Series I-2 Preferred Stock [Member]
Number of shares issued upon conversion, value													$ 1,500,000
Number of shares issued upon conversion			2,176.975
Number of shares converted												982.101		1,286.141